Grupo Investigación GC09 Nutrigenomics, Metabolic Syndrome, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, 14071 Córdoba, Spain.
Grupo Investigación GC12 Clinical and Epidemiological Research in Primary Care, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, 14071 Córdoba, Spain.
Int J Environ Res Public Health. 2020 Mar 14;17(6):1891. doi: 10.3390/ijerph17061891.
The prevalence of obesity continues to grow, resulting in metabolic syndrome and increasing economic burden for health systems. The objectives were to measure the ability of the NIM-MetS test, previously used in the adults, for the early and sustainable detection of the Metabolic Syndrome (MetS) in children and adolescents. Moreover, to determine the economic burden of the children with MetS. Furthermore, finally, to use and implement the NIM-MetS test, via a self-created online software, as a new method to determine the risk of MetS in children. The method used was an observational study using different instruments (NIM-MetS test, International Diabetes Federation (IDF), or Cook) and measures (body mass index). Additionally, the economic burden was estimated via a research strategy in different databases, e.g., PubMed, to identify previous papers. The results (N = 265 children, age from 10-12) showed that 23.1% had obesity and 7.2% hypertension. The prevalence of MetS using the NIM-Mets was 5.7, and the cost of these children was approximate 618,253,99 euros. Finally, a model was obtained and later implemented in a web platform via simulation. The NIM-MetS obtained is a non-invasive method for the diagnosis of risk of MetS in children.
肥胖症的患病率持续上升,导致代谢综合征,并给卫生系统带来了越来越大的经济负担。目的是衡量以前在成年人中使用的 NIM-MetS 测试在儿童和青少年中早期和可持续检测代谢综合征(MetS)的能力。此外,还确定了患有 MetS 的儿童的经济负担。最后,还使用并实施了 NIM-MetS 测试,通过一个自创的在线软件,作为一种新的方法来确定儿童患 MetS 的风险。使用的方法是一种观察性研究,使用了不同的仪器(NIM-MetS 测试、国际糖尿病联合会(IDF)或 Cook)和测量方法(体重指数)。此外,还通过在不同的数据库中进行研究策略来估计经济负担,例如 PubMed,以确定以前的论文。结果(N = 265 名年龄在 10-12 岁的儿童)显示,23.1%的儿童肥胖,7.2%的儿童患有高血压。使用 NIM-Mets 检测的 MetS 患病率为 5.7%,这些儿童的费用约为 618,253,99 欧元。最后,获得了一个模型,并通过模拟在一个网络平台上实现。NIM-MetS 是一种非侵入性的儿童代谢综合征风险诊断方法。